However, previous research has shown that the use of an anti-CTLA-4 antibody treatment counteracted the protection from renal IRI induced by N,N-dimethylsphingosine (DMS) [57], suggesting that CTLA-4 is also involved in the protective effects of Tregs in AKI. The gene discussed is CTLA4; the disease is acute kidney injury.